Experimental antiinflammatory and analgesic studies with 3-trifluoromethyl-s-triazolo (3,4-a)-isoquinoline.
D000085:Acetates / Q000037:antagonists & inhibitors; D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D004064:Digestive System / Q000187:drug effects; D004487:Edema / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000188:drug therapy; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000096:biosynthesis; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D012756:Sheep; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use*
D000085:Acetates; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D007546:Isoquinolines; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D014230:Triazoles; D010653:Phenylbutazone; D001241:Aspirin